Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12


I2-Mediated Oxidative C-N and N-S Bond Formation in Water: A Metal-Free Synthesis of 4,5-Disubstituted/N-Fused 3-Amino-1,2,4-triazoles and 3-Substituted 5-Amino-1,2,4-thiadiazoles.

Jatangi N, Tumula N, Palakodety RK, Nakka M.

J Org Chem. 2018 May 18;83(10):5715-5723. doi: 10.1021/acs.joc.8b00753. Epub 2018 May 8.


Biomarker significance of plasma and tumor miR-21, miR-221, and miR-106a in osteosarcoma.

Nakka M, Allen-Rhoades W, Li Y, Kelly AJ, Shen J, Taylor AM, Barkauskas DA, Yustein JT, Andrulis IL, Wunder JS, Gorlick R, Meltzer PS, Lau CC, Man TK; TARGET osteosarcoma consortium.

Oncotarget. 2017 May 27;8(57):96738-96752. doi: 10.18632/oncotarget.18236. eCollection 2017 Nov 14.


Do Intraocular Pressure Measurements Under Anesthesia Reflect the Awake Condition?

Nakka M, Kumar PS, Koshy PG, Rout US, Garudadri CS, Senthil S.

J Glaucoma. 2018 Jan;27(1):e28-e29. doi: 10.1097/IJG.0000000000000793. No abstract available.


I2-Catalyzed Oxidative N-S Bond Formation: Metal-Free Regiospecific Synthesis of N-Fused and 3,4-Disubstituted 5-Imino-1,2,4-thiadiazoles.

Tumula N, Jatangi N, Palakodety RK, Balasubramanian S, Nakka M.

J Org Chem. 2017 May 19;82(10):5310-5316. doi: 10.1021/acs.joc.7b00646. Epub 2017 May 4.


A novel prognostic model for osteosarcoma using circulating CXCL10 and FLT3LG.

Flores RJ, Kelly AJ, Li Y, Nakka M, Barkauskas DA, Krailo M, Wang LL, Perlaky L, Lau CC, Hicks MJ, Man TK.

Cancer. 2017 Jan 1;123(1):144-154. doi: 10.1002/cncr.30272. Epub 2016 Aug 16.


p27 Is a Candidate Prognostic Biomarker and Metastatic Promoter in Osteosarcoma.

Li Y, Nakka M, Kelly AJ, Lau CC, Krailo M, Barkauskas DA, Hicks JM, Man TK.

Cancer Res. 2016 Jul 1;76(13):4002-11. doi: 10.1158/0008-5472.CAN-15-3189. Epub 2016 Apr 19.


A Child with Recurrent Abdominal Pain: A Cross-road between Pediatrics, Neurology and Psychiatry.

Nagarajitha N, Nakka M, Kosaraju SK, Adusumalli TC.

Indian J Pediatr. 2016 Jun;83(6):609-10. doi: 10.1007/s12098-015-2029-3. Epub 2016 Jan 30. No abstract available.


Androgen receptor and its splice variant, AR-V7, differentially regulate FOXA1 sensitive genes in LNCaP prostate cancer cells.

Krause WC, Shafi AA, Nakka M, Weigel NL.

Int J Biochem Cell Biol. 2014 Sep;54:49-59. doi: 10.1016/j.biocel.2014.06.013. Epub 2014 Jul 4.


Target gene-specific regulation of androgen receptor activity by p42/p44 mitogen-activated protein kinase.

Agoulnik IU, Bingman WE 3rd, Nakka M, Li W, Wang Q, Liu XS, Brown M, Weigel NL.

Mol Endocrinol. 2008 Nov;22(11):2420-32. doi: 10.1210/me.2007-0481. Epub 2008 Sep 11.


Androgens modulate expression of transcription intermediary factor 2, an androgen receptor coactivator whose expression level correlates with early biochemical recurrence in prostate cancer.

Agoulnik IU, Vaid A, Nakka M, Alvarado M, Bingman WE 3rd, Erdem H, Frolov A, Smith CL, Ayala GE, Ittmann MM, Weigel NL.

Cancer Res. 2006 Nov 1;66(21):10594-602.

Supplemental Content

Support Center